logo-loader
viewHeartseed

Heartseed developing heart failure treatment

Heartseed Inc CEO Keiichi Fukuda sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Tokyo-based biotechnology company is developing a treatment for heart failure, and recently raised $26M in Series B funding.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Faron Pharma CEO confident as he looks ahead to new Traumakine study

Faron Pharmaceuticals Oy (LON:FARN) (FIRSTNORTH:FARON) CEO Dr Markku Jalkanen caught up with Proactive London's Andrew Scott soon after announcing they've amended the protocol for a second phase III study of its drug for acute respiratory distress syndrome (ARDS). The tweak's in response to...

18 hours, 5 minutes ago

2 min read